| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |